Safety and Tolerability of CMAB017 In Patients With Advanced Solid Tumors
Safety and Tolerability of CMAB017 In Patients With Advanced Solid Tumors
Recruiting · NCT06933069 · Registry updated 2025-09-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Tolerability of CMAB017 In Patients With Advanced Solid Tumors | Solid Malignancies | Recruiting | Phase 1 | 2025-09-11 | NCT06933069 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Taizhou Mabtech Pharmaceutical Co.,Ltd | 5 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Shanghai East Hospital | Shanghai | China | 12 |